TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$2.58
-0.10 (-3.73%)
Open$2.69
Previous Close$2.68
Day High$2.70
Day Low$2.53
52W High$43.65
52W Low$2.48
Volume—
Avg Volume63.7K
Market Cap24.67M
P/E Ratio—
EPS$-8.36
SectorPharmaceuticals
Analyst Ratings
Buy
14 analysts
Price Target
+1,375.6% upside
Current
$2.58
$2.58
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 44.02M | 65.03M | 10.81M |
| Net Income | -437,127,481 | -581,114,819 | 2.98M |
| Profit Margin | -993.0% | -943.3% | 27.6% |
| EBITDA | -403,578,856 | -566,321,880 | 3.89M |
| Free Cash Flow | — | — | 2.37M |
| Rev Growth | -32.3% | -32.3% | +19.2% |
| Debt/Equity | — | — | 0.91 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |